Literature DB >> 31084257

Clinical course of asymptomatic deep vein thrombosis after total knee arthroplasty in Japanese patients.

Toshiyuki Tateiwa1, Tsunehito Ishida1, Toshinori Masaoka1, Takaaki Shishido1, Yasuhito Takahashi1,2, Atsuko Onozuka3, Jun Nishida1, Kengo Yamamoto1.   

Abstract

PURPOSE: The purpose of the present study was to follow up Japanese patients with deep vein thrombosis (DVT) after total knee arthroplasty (TKA) and also to examine factors associated with residual thrombus within the sixth postoperative month.
METHODS: DVT evaluation was performed by noninvasive venous ultrasonography. We retrospectively reviewed 88 Japanese patients (88 knees) receiving primary unilateral TKA, who had no preoperative DVT. We examined the influence of the following four factors on postoperative DVT: (1) patient factors (age, sex, body height, body weight, and body mass index), (2) surgical factors (operation time, bleeding amount, avascularization time, and anesthesia method), (3) postoperative factors (bleeding amount, period to ambulation, period of venous foot pump use, and ratio of graduated compression stocking use), and (4) DVT conditional factors (location, length, number of vein branches, and the presence of >5 mm vasodilatation).
RESULTS: The total prevalence of venous thromboembolism (VTE) was 62.5% (55 of the 88 patients). Among the 55 VTE patients, the rates of distal and proximal DVT were 96.4% and 3.6%, respectively. Bilateral DVT was found in 34.5%, while unilateral DVT on the surgical and nonsurgical sides were 52.7% and 12.7%, respectively. Asymptomatic pulmonary embolism was 1.8%. DVT was exacerbated in five patients (11.9%), of whom three showed additional thrombus formation. The remaining two patients had thrombus elongation or propagation from distal to proximal veins. In comparisons between thrombus-unresolved and -resolved groups within the sixth postoperative month, statistical significances were found in the incidence of bilateral DVT (50.0% vs. 15.4%, p = 0.02) and unilateral DVT (43.8% vs. 76.9%, p = 0.02). On the other hand, operation time (107.0 ± 17.3 min vs. 94.5 ± 11.9 min, p = 0.01) and avascularization time (99.8 ± 17.6 min vs. 88.0 ± 11.5 min, p = 0.01) in bilateral DVT patients were significantly longer than in unilateral ones.
CONCLUSION: Our results suggest that an extended operation and avascularization time may be a risk factor for bilateral DVT and residual thrombus over 6 months.

Entities:  

Keywords:  deep vein thrombosis; total knee arthroplasty; ultrasonography; venous thromboembolism

Mesh:

Year:  2019        PMID: 31084257     DOI: 10.1177/2309499019848095

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  4 in total

1.  Anterior tibial subluxation measured under a modified protocol is positively correlated with posterior tibial slope: a comparative study of MRI measurement methods.

Authors:  Cheng Wang; Jian-Quan Wang; Zhi-Yu Zhang; Xiao-Yu Pan; Pakezhati Maimaitijiang; Ling-Yu Meng; Zi-Yi He; Qiang Zhao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-02-26       Impact factor: 4.114

2.  Risk factor for venous thromboembolism after high tibial osteotomy -analysis of patient demographics, medical comorbidities, operative valuables, and clinical results.

Authors:  Mitsuaki Kubota; Youngji Kim; Tetsuya Inui; Taisuke Sato; Haruka Kaneko; Muneaki Ishijima
Journal:  J Orthop       Date:  2021-05-04

3.  Does intraoperative mechanical prophylaxis prevent venous thromboembolism in total knee arthroplasty? - effectiveness of passive-assisted ankle motion in surgical/non-surgical side.

Authors:  Toshiyuki Tateiwa; Tsunehito Ishida; Toshinori Masaoka; Takaaki Shishido; Yasuhito Takahashi; Jun Nishida; Kengo Yamamoto
Journal:  Arthroplasty       Date:  2021-09-03

4.  Construction of Prediction Model of Deep Vein Thrombosis Risk after Total Knee Arthroplasty Based on XGBoost Algorithm.

Authors:  Yuhuan Chen; Yingqing Jiang
Journal:  Comput Math Methods Med       Date:  2022-01-25       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.